In yet another sign of positive things to come for our favourite company, RHT.V, Beacon Securities Limited initiated coverage yesterday (February 14, 2018) with a $3.00 12-month target price. If the caption of their report serves as a summary of what you need to know (and themoneynarrative thinks it does), then “Monitor This Stock: Explosive Growth Ahead” should have investors pretty excited.
Beacon Securities likes the investment thesis, and advises readers as follows:
We believe the exponential increase in healthcare costs associated with managing at-home individuals with multiple chronic conditions has created the opportunity for Reliq to win significant market share with its remote patient monitoring software platform. With a slew of early wins and a very strong pipeline of opportunities, we believe the company is well positioned to show meaningful organic growth and operating leverage over our forecast period.
Themoneynarrative agrees with their advice, although their $3.00 12-month target price is very conservative and likely will be revised upwards during 2018 with news of positive developments. We are particularly pleased that RHT.V is starting to make serious inroads with respect to investor awareness. Investors should expect additional analyst coverage in the months ahead. Institutional money is already helping provide significant positive share price momentum, and a $2.00+ share price is marginable (although some financial institutions set a higher threshold, typically $3.00).
Themoneynarrative believes so strongly in RHT.V, that we suggest that the caption quoted above be amended to read: “Own This Stock for the Long Term: Explosive Growth Ahead”. Opportunities like this (as we have been saying for quite some time) don’t come along very often.